Open AccessTargeting Oncogenic miR-181a-2-3p Inhibits Growth and Suppresses Cisplatin Resistance of Gastric Cancer
Author(s) -
Lei Jin,
Xuemei Ma,
Nan Zhang,
Qian Zhang,
Xueming Chen,
Zhongtao Zhang,
Guoqian Ding,
Hongzhi Yu
Publication year - 2021
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
ISSN - 1179-1322
DOI - 10.2147/cmar.s332713
Subject(s) - microrna , cisplatin , cancer , flow cytometry , cell growth , cancer research , transfection , biology , apoptosis , cell culture , chemotherapy , oncology , microbiology and biotechnology , medicine , gene , genetics
This study aimed to explore the value of miR-181a-2-3p in cisplatin (DDP) treatment effectiveness prediction, and to reveal the function underlying the reversal of DDP resistance in patients with gastric cancer (GC).